Adenocarcinoma of the pancreas - past, present and futureLYGIDAKIS, N. J; JAIN, Sundeep; SACCHI, Marco et al.Hepato-gastroenterology. 2005, Vol 52, Num 64, pp 1281-1292, issn 0172-6390, 12 p.Article

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitisBLOOMSTON, Mark; FRANKEL, Wendy L; PETROCCA, Fabio et al.JAMA, the journal of the American Medical Association. 2007, Vol 297, Num 17, pp 1901-1908, issn 0098-7484, 8 p.Article

Differential expression profiling of human pancreatic adenocarcinoma and healthy pancreatic tissueZHAOHUI LU; LIPING HU; EVERS, Stefan et al.Proteomics (Weinheim. Print). 2004, Vol 4, Num 12, pp 3975-3988, issn 1615-9853, 14 p.Article

Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survivalFERRONE, Cristina R; KATTAN, Michael W; TOMLINSON, James S et al.Journal of clinical oncology. 2005, Vol 23, Num 30, pp 7529-7535, issn 0732-183X, 7 p.Article

High-b value diffusion-weighted MRI for detecting pancreatic adenocarcinoma : Preliminary resultsICHIKAWA, Tomoaki; ERTURK, Sukru Mehmet; MOTOSUGI, Utarou et al.American journal of roentgenology (1976). 2007, Vol 188, Num 2, pp 409-414, issn 0361-803X, 6 p.Article

Non-pancreatic periampullary adenocarcinomas: An explanation for favorable prognosisKATZ, Matthew H. G; BOUVET, Michael; AL-REFAIE, Waddah et al.Hepato-gastroenterology. 2004, Vol 51, Num 57, pp 842-846, issn 0172-6390, 5 p.Article

Adénocarcinome du pancréas = Pancreatic adenocarcinomaRIDEREAU-ZINS, Catherine; AUBE, Christophe.La Presse médicale (1983). 2006, Vol 35, Num 2, pp 353-354, issn 0755-4982, 2 p., CAH2Article

Impact of interferon-α in combined chemoradioimmunotherapy for pancreatic adenocarcinoma (CapRI) : First data from the immunomonitoringSCHMIDT, Jan; JÄGER, Dirk; HOFFMANN, Kartin et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 1, pp 108-115, issn 1524-9557, 8 p.Article

Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspirationMISHRA, Girish; YIWEN ZHAO; SHEN, Perry et al.Gastrointestinal endoscopy. 2006, Vol 63, Num 4, pp 648-654, issn 0016-5107, 7 p.Article

Potential role of jun activation domain-binding protein 1 as a negative regulator of p27^kip1 in pancreatic adenocarcinomaKOUVARAKI, Maria A; KORAPATI, Anita L; RASSIDAKIS, George Z et al.Cancer research (Baltimore). 2006, Vol 66, Num 17, pp 8581-8589, issn 0008-5472, 9 p.Article

Intraductal tubular adenocarcinoma of the pancreas diagnosed before surgery by transpapillary biopsy: case report and reviewITO, Kei; FUJITA, Naotaka; NODA, Yutaka et al.Gastrointestinal endoscopy. 2005, Vol 61, Num 2, pp 325-329, issn 0016-5107, 5 p.Article

Dose escalation of concurrent hypofractionated radiotherapy and continuous infusion 5-FU-chemotherapy in advanced adenocarcinoma of the pancreasZIMMERMANN, Frank B; JEREMIC, Branislav; LERSCH, Christian et al.Hepato-gastroenterology. 2005, Vol 52, Num 61, pp 246-250, issn 0172-6390, 5 p.Article

Radiotherapy in the adjuvant management of pancreatic adenocarcinomaABRAMS, Ross A.Seminars in oncology. 2005, Vol 32, Num 6, issn 0093-7754, S30-S32, SUP9Conference Paper

A clinically relevant model of human pancreatic adenocarcinoma identifies patterns of metastasis associated with alterations of the TGF-β/Smad4 signaling pathwayHOLLOWAY, Shane; DAVIS, Mishel; JABER, Raffat et al.International journal of gastrointestinal cancer. 2003, Vol 33, Num 1, pp 61-69, issn 1537-3649, 9 p.Article

Strategies for screening for pancreatic adenocarcinoma in high-risk patientsCANTO, Marcia Irene.Seminars in oncology. 2007, Vol 34, Num 4, pp 295-302, issn 0093-7754, 8 p.Article

MUC4-expressing pancreatic adenocarcinomas show elevated levels of both T_H1 and T_H2 cytokines : Potential pathobioloric implicationsANDRIANIFAHANANA, Mahefatiana; CHAUHAN, Subhash C; CHOUDHURY, Amit et al.The American journal of gastroenterology. 2006, Vol 101, Num 10, pp 2319-2329, issn 0002-9270, 11 p.Article

Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinomaFERRONE, Cristina R; FINKELSTEIN, Dianne M; THAYER, Sarah P et al.Journal of clinical oncology. 2006, Vol 24, Num 18, pp 2897-2902, issn 0732-183X, 6 p.Article

MDCT of pancreatic adenocarcinoma : Optimal imaging phases and multiplanar reformatted imagingICHIKAWA, Tomoaki; MEHMET ENURK, Sukru; SOU, Hironobu et al.American journal of roentgenology (1976). 2006, Vol 187, Num 6, pp 1513-1520, issn 0361-803X, 8 p.Article

Pancreatic adenocarcinoma : signs of vascular invasion determined by multi-detector row CTLI, H; ZENG, M. S; ZHOU, K. R et al.British journal of radiology. 2006, Vol 79, Num 947, pp 880-887, issn 0007-1285, 8 p.Article

CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesionsDUXBURY, Mark S; MATROS, Evan; CLANCY, Thomas et al.Annals of surgery. 2005, Vol 241, Num 3, pp 491-496, issn 0003-4932, 6 p.Article

Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathwaySALEEM, Mohammad; KAUR, Satwinderjeet; KWEON, Mee-Hyang et al.Carcinogenesis (New York. Print). 2005, Vol 26, Num 11, pp 1956-1964, issn 0143-3334, 9 p.Article

Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas. DiscussionMESZOELY, Ingrid M; LEE, John S; WATSON, James C et al.The American surgeon. 2004, Vol 70, Num 3, pp 208-214, issn 0003-1348, 7 p.Conference Paper

The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. DiscussionBERGER, Adam C; WATSON, James C; ROSS, Eric A et al.The American surgeon. 2004, Vol 70, Num 3, pp 235-240, issn 0003-1348, 6 p.Conference Paper

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: Analysis of histopathology and outcomeSASSON, Aaron R; WETHERINGTON, R. Wesley; HOFFMAN, John P et al.International journal of gastrointestinal cancer. 2003, Vol 34, Num 2-3, pp 121-127, issn 1537-3649, 7 p.Article

MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanismsSINGH, A. P; CHAUHAN, S. C; ANDRIANIFAHANANA, M et al.Oncogene (Basingstoke). 2007, Vol 26, Num 1, pp 30-41, issn 0950-9232, 12 p.Article